Gateway Analytical to Present on Proactive vs. Reactive Testing for Glass Delamination in Pharmaceuticals at Annual Parenteral Drug Association Meeting

Share Button

PITTSBURGH, March 7, 2016 — Gateway Analytical announced today that they will give a scientific poster presentation on proactive and reactive glass delamination analysis in addition to exhibiting at the upcoming 2016 Parenteral Drug Association (PDA) Annual Meeting and Exposition in San Antonio, Texas. The 2016 PDA Annual Meeting features some of the latest and most inclusive information about traditional and Biopharmaceutical science, manufacturing technology, quality and evolving regulations. At this event, participants and companies get a glimpse of what the future of manufacturing holds, so they can prepare for the changes that are already underway in the industry.

At the conference, Emily Landsperger, Scientist at Gateway Analytical, will present a scientific poster session entitled, “Proactive vs. Reactive Testing for Glass Delamination in Pharmaceuticals” during the March 15th session. The presentation will recommend “approaches to predict the potential of a drug product to cause formation of glass particles and delamination and to detect their occurrence.” Conference attendees are encouraged to continue the conversation at Gateway Analytical’s exhibit, booth #306. Also, a webinar on this subject will be presented by Gateway Analytical on March 23rd.

“We are excited to discuss our service offerings with the PDA community in order to determine how Gateway Analytical can assist them with day-to-day issues faced during pharmaceutical product development, such as identifying foreign particulates or glass delamination analysis,” said David Exline, Senior Vice President at Gateway Analytical. “We have expanded our capabilities in order to meet customer and industry demand, giving companies the option to choose one analytical laboratory to support all their outsourcing needs, and streamline turnaround time in the process.”

Gateway Analytical is a full service, cGMP compliant, ISO 9001:2008 certified, ISO 17025:2005 certified, DEA licensed, FDA registered and inspected laboratory with specialized expertise in techniques for chemically specific analysis and particulate contamination identification. For more information on Gateway Analytical services, contact us at info@gatewayanalytical.com or visit our website, www.gatewayanalytical.com.

###

About Gateway Analytical

Based in Gibsonia, Pa., Gateway Analytical, LLC partners with companies in need of high-quality laboratory analysis that do not have the time, resources or capabilities for specialized, comprehensive testing. Through conventional and innovative testing methods, the company provides expert laboratory services and analytical solutions for the pharmaceutical, forensic and materials science industries.

Gateway Analytical is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation.

 

About ChemImage

ChemImage Corporation, a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company’s proprietary, state-of-the-art imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.

ChemImage’s headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.

For more information contact:
Gateway Analytical
Press Contact: Tifanie Tiberio, Marketing Events & Media Manager
5316 William Flynn Highway
Gibsonia, PA 15044
Phone: +1 (724) 443-1900
Web: www.gatewayanalytical.com
Email: info@gatewayanalytical.com

Leave a Reply